Cannara Biotech Inc. (LOVE.V) TSXV

1.85

+0.04(+2.21%)

Updated at January 14 01:27PM

Currency In CAD

Valuation

Market Cap168.12M
Enterprise Value195.34M
P/E Ratio15.25
PEG Ratio-0.86
Price/Sales Ratio1.53
Price/Book Ratio1.95
Enterprise/Revenue1.78
Enterprise/EBITDA6.75

Fiscal Year

Fiscal YearAugust 31, 2025
Most Recent QuarterAugust 31, 2025

Profitability

Profit Margin0.12
Operating Margin0.21

Management Effectiveness

Return On Assets0.08
Return On Equity0.14

Income Statement

Revenue107.32M
Revenue/Share0.98
Gross Profit47.22M
EBITDA28.18M
Net Income13.08M
Diluted EPS0.14

Balance Sheet

Total Cash14.36M
Total Cash/Share0.13
Total Debt41.58M
Total Debt/Equity0.41
Current Ratio2.4
Book Value Per Share0.93

Price History

52-Week Change115.48
52-Week High1.99
52-Week Low0.82
Moving Average 50 Days1.72
Moving Average 200 Days1.6

Statistics

Average Volume49,282
Shares Outstanding90.85M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateFebruary 13, 2023